Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Cell Death Discovery|August 26, 2024
Superoxide dismutase 1 mediates adaptation to the tumor microenvironment of glioma cells via mammalian target of rapamycin complex 1Sven König, Florian Strassheimer, Nadja I Brandner, et al.
Cancers|November 3, 2020
Non-Invasive Measurement of Drug and 2-HG Signals Using <sup>19</sup>F and <sup>1</sup>H MR Spectroscopy in Brain Tumors Treated with the Mutant IDH1 Inhibitor BAY1436032Katharina J Wenger, Christian Richter, Michael C Burger, et al.
Cancers|October 23, 2020
Cetuximab-Mediated Protection from Hypoxia- Induced Cell Death: Implications for Therapy Sequence in Colorectal CancerHans Urban, Gabriele D Maurer, Anna-Luisa Luger, et al.
Frontiers in Immunology|January 20, 2022
Immune Checkpoint Inhibitor-Induced Cerebral Pseudoprogression: Patterns and CategorizationHans Urban, Eike Steidl, Elke Hattingen, et al.
Brain : a Journal of Neurology|October 4, 2017
Mammalian target of rapamycin complex 1 activation sensitizes human glioma cells to hypoxia-induced cell deathAnna-Luisa Thiepold, Nadja I Lorenz, Martha Foltyn, et al.
Clinical and Translational Medicine|November 18, 2024
An AMP-activated protein kinase-PGC-1α axis mediates metabolic plasticity in glioblastomaBenedikt Sauer, Jan Kueckelhaus, Nadja I Lorenz, et al.
Cell Death Discovery|March 28, 2026
Targeting glioblastoma mitochondrial metabolism with S-Gboxin induces cytotoxicity under conditions of the tumor microenvironmentJan-Béla Weinem, Hans Urban, Benedikt Sauer, et al.
Cancers|August 7, 2020
Activation of Epidermal Growth Factor Receptor Sensitizes Glioblastoma Cells to Hypoxia-Induced Cell DeathAnna-Luisa Luger, Nadja I Lorenz, Hans Urban, et al.
Acta Neuropathologica Communications|November 21, 2024
Detection of diagnostic somatic copy number alterations from cerebrospinal fluid cell-free DNA in brain tumor patientsSvenja Klinsing, Julia Beck, Katharina J Weber, et al.
Cells|April 12, 2024
A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1Kai Zhao, Madita Braun, Leonie Meyer, et al.
Pageof 3